<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02712528</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1160080</org_study_id>
    <nct_id>NCT02712528</nct_id>
  </id_info>
  <brief_title>Recovery Profiles of Remifentanil-based Regimen for Cardiac Surgery</brief_title>
  <official_title>Recovery Profiles of Remifentanil-based vs. Sevoflurane-sufentanil Combined Regimen for Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Backgrounds: Monitoring of Bispectral index (BIS) has been regarded as useful to determine
      the degree of intraoperative hypnosis. Major factors of postoperative recovery after cardiac
      surgery include patient's recovery in cognitive function from the postoperative residual
      effects of anesthetics, such as opioids and sedatives, administered during intraoperative
      period. Therefore employing anesthetic regimens which can provide earlier recovery in
      cognitive function would be beneficial in facilitating fast-track cardiac surgery with
      earlier postoperative extubation and discharge from the intensive care unit (ICU).

      Previous investigations suggested efficacy of BIS in evaluating the degree of postoperative
      hypnosis in the ICU.

      The present study compares the time for reaching BIS greater than 80 after using 2 different
      anesthesia regimens for cardiac surgery, remifentanil-based regimen and
      sevoflurane-sufentanil balanced regimen.

      Analyzing the changes immediately after cardiac surgery would be useful to determine the
      degree of patient's postoperative emergence.

      Materials and Methods:

      During study period, patients undergoing elective cardiac surgery in Konkuk University
      Medical Center are randomly assigned to get remifentanil-based regimen consisting of
      remifentanil 0.75 mcg/kg/min and supplemental propofol for maintaining BIS 40-60 (Group R) or
      sevoflurane (end-tidal 1.2-2.8 vol%) and sufentanil (0.015 mcg/kg/min) balanced regimen in
      Group S.

      All patients get intravenous patient controlled anesthesia consisting of alfentanyl and
      ondansetron after surgery. Supplemental remifentanil 0.25-0.3 mcg/kg/min is administered
      during postoperative 2 hours in Group R.

      As a primary objective, inter-group difference in the time for achieving BIS greater than 80
      is determined.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to reach BIS &gt; 80</measure>
    <time_frame>1 minute</time_frame>
    <description>Time to reach BIS &gt; 80 after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extubation time</measure>
    <time_frame>1 minute</time_frame>
    <description>Time to perform extubation after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>remifentanil-based</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>remifentanil-based regimen consisting of remifentanil 0.75 mcg/kg/min and supplemental propofol for maintaining BIS 40-60</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane-sufentanil balanced</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>balanced sevoflurane (end-tidal 1.2-2.8 vol%) and sufentanil (0.015 mcg/kg/min) regimen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanil-based</intervention_name>
    <arm_group_label>remifentanil-based</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane-sufentanil balanced</intervention_name>
    <arm_group_label>sevoflurane-sufentanil balanced</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing elective coronary artery bypass surgery

        Exclusion Criteria:

          -  combined valve surgery

          -  preoperative intraaortic balloon pumping

          -  preoperative low cardiac output syndrome

          -  chronic obstructive pulmonary disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tae-Yop Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konkuk University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05030</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>March 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2016</study_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>bispectral index</keyword>
  <keyword>extubation</keyword>
  <keyword>recovery</keyword>
  <keyword>remifentanil</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

